title: In Vivo validation of a bioinformatics based tool to identify reduced replication capacity in HIV-1.
abstract: Although antiretroviral drug resistance is common in treated HIV infected individuals, it is not a consistent indicator of HIV morbidity and mortality. To the contrary, HIV resistance-associated mutations may lead to changes in viral fitness that are beneficial to infected individuals. Using a bioinformatics-based model to assess the effects of numerous drug resistance mutations, we determined that the D30N mutation in HIV-1 protease had the largest decrease in replication capacity among known protease resistance mutations. To test this in silico result in an in vivo environment, we constructed several drug-resistant mutant HIV-1 strains and compared their relative fitness utilizing the SCID-hu mouse model. We found HIV-1 containing the D30N mutation had a significant defect in vivo, showing impaired replication kinetics and a decreased ability to deplete CD4+ thymocytes, compared to the wild-type or virus without the D30N mutation. In comparison, virus containing the M184V mutation in reverse transcriptase, which shows decreased replication capacity in vitro, did not have an effect on viral fitness in vivo. Thus, in this study we have verified an in silico bioinformatics result with a biological assessment to identify a unique mutation in HIV-1 that has a significant fitness defect in vivo.
authors: Department of Biostatistics, UCLA School of Public Health, Los Angeles, California 90095, USA. cr@ucla.edu
authors: Christina M R
authors: CM
authors: Kitchen
authors: Paul
authors: P
authors: Krogstad
authors: Scott G
authors: SG
authors: Kitchen
references: AIDS. 1997;11 Suppl A:S17-24
references: 9451962
references: AIDS Res Hum Retroviruses. 2001 Apr 10;17(6):517-23
references: 11350665
references: Ann Intern Med. 1999 Jul 20;131(2):81-7
references: 10419445
references: Antimicrob Agents Chemother. 1998 Oct;42(10):2637-44
references: 9756769
references: AIDS Read. 2006 Oct;16(10):556-9
references: 17096474
references: Biometrics. 2002 Mar;58(1):145-56
references: 11890310
references: Clin Infect Dis. 1999 Dec;29(6):1423-30
references: 10585790
references: Nature. 1993 Jun 24;363(6431):732-6
references: 8515816
references: Cell. 1990 Apr 20;61(2):213-22
references: 2331748
references: J Virol. 2003 Apr;77(8):4836-47
references: 12663790
references: Nature. 1995 Jan 12;373(6510):123-6
references: 7816094
references: J Infect Dis. 2005 Nov 1;192(9):1537-44
references: 16206068
references: J Virol. 1998 Sep;72(9):7632-7
references: 9696866
references: Clin Microbiol Rev. 2007 Oct;20(4):550-78
references: 17934074
references: N Engl J Med. 2001 Feb 15;344(7):472-80
references: 11172188
references: J Virol. 1997 Aug;71(8):5713-22
references: 9223457
references: Curr Opin Infect Dis. 2001 Feb;14(1):23-8
references: 11979111
references: PLoS One. 2007 Aug 01;2(7):e655
references: 17668043
references: Nat Med. 2001 Jun;7(6):712-8
references: 11385509
references: J Acquir Immune Defic Syndr. 2000 Dec 1;25(4):289-95
references: 11114828
references: Ann Intern Med. 2000 Sep 19;133(6):401-10
references: 10975957
references: Antimicrob Agents Chemother. 2002 Mar;46(3):708-15
references: 11850252
references: Nature. 1989 Aug 3;340(6232):397-400
references: 2666861
references: Nature. 1995 Jan 12;373(6510):117-22
references: 7529365
references: J Virol. 2003 Sep;77(18):10172-5
references: 12941931
references: AIDS. 2006 Apr 4;20(6):795-803
references: 16549962
references: J Med Virol. 2001 Oct;65(2):218-24
references: 11536226
references: J Virol. 2000 Sep;74(18):8524-31
references: 10954553
references: J Virol. 2002 Nov;76(21):11104-12
references: 12368352
references: J Infect Dis. 2000 Mar;181(3):946-53
references: 10720517
references: AIDS. 2002 Jan 25;16(2):201-7
references: 11807304
references: AIDS. 1999 Dec 3;13(17):2349-59
references: 10597776
references: AIDS. 1997 Nov 15;11(14):F113-6
references: 9386799
references: Lancet. 1999 Mar 13;353(9156):863-8
references: 10093977
references: J Virol. 1999 May;73(5):3744-52
references: 10196268
references: AIDS. 1999 Apr 16;13(6):F35-43
references: 10397555
references: AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S235-9
references: 9814949
references: AIDS. 2003 Feb 14;17(3):361-70
references: 12556690
references: Virology. 2003 Sep 30;314(2):536-48
references: 14554082
references: J Virol. 2001 Nov;75(21):10073-89
references: 11581376
references: AIDS. 2010 Jan 2;24(1):45-53
references: 19915448
references: Pharmacol Ther. 2000 May;86(2):145-70
references: 10799712
references: Stat Med. 2007 Feb 28;26(5):975-90
references: 16755527
references: Antimicrob Agents Chemother. 2004 Sep;48(9):3552-5
references: 15328124